The use of bispecific antibodies (BsAb) before chimeric antigen receptor T-cell therapy (CAR-T) appeared to be a more optimal ...

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology have been updated to include duvelisib (Copiktra) as a category 2A treatment option for cutaneous T-cell ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Trial data on epcoritamab plus rituximab-lenalidomide, a novel CELMoD agent, late-line CAR-T cell therapy, and selecting ...

Researchers at the Johns Hopkins Kimmel Cancer Center's Ludwig Center developed a new treatment that selectively targets ...

Studies presented at the ASH Annual Meeting 2025 highlighted a novel prognostic approach and emerging treatment strategies in lymphoma.

Immune cells called B cells make antibodies that fight off invading bacteria, viruses and other foreign substances. During ...

Full House’s Dave Coulier has announced he is undergoing treatment for tongue cancer, a year after being diagnosed with non-Hodgkin lymphoma. The 66-year-old actor shared an update on his health.